The continuing increase in the incidence of primary central nervous system non-Hodgkin lymphoma: A surveillance, epidemiology, and End Results analysis

Primary central nervous system lymphoma (PCNSL) is an extranodal form of non-Hodgkin lymphoma arising in the craniospinal axis. The incidence of PCNSL appears to be increasing. PCNSL incidence data from 1973-1997 were obtained from the nine Surveillance, Epidemiology and End Results (SEER) registrie...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Cancer 2002-10, Vol.95 (7), p.1504-1510
Hauptverfasser: OLSON, Janet E, JANNEY, Carol A, RAO, Ravi D, CERHAN, James R, KURTIN, Paul J, SCHIFF, David, KAPLAN, Richard S, O'NEILL, Brian Patrick
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 1510
container_issue 7
container_start_page 1504
container_title Cancer
container_volume 95
creator OLSON, Janet E
JANNEY, Carol A
RAO, Ravi D
CERHAN, James R
KURTIN, Paul J
SCHIFF, David
KAPLAN, Richard S
O'NEILL, Brian Patrick
description Primary central nervous system lymphoma (PCNSL) is an extranodal form of non-Hodgkin lymphoma arising in the craniospinal axis. The incidence of PCNSL appears to be increasing. PCNSL incidence data from 1973-1997 were obtained from the nine Surveillance, Epidemiology and End Results (SEER) registries. To limit the influence of the human immunodeficiency virus on incidence rates, data of never-married males and females and persons of unknown marital status were excluded. As a surrogate for new technology, SEER data were reviewed by dates of diagnosis (surrogate for imaging) and compared with glioma incidence (surrogate for stereotactic neurosurgery and improved diagnostic neuropathology). Age-adjusted incidence rates were estimated and compared for the period prior to computed tomography (CT) (1973-1984) and the magnetic resonance imaging (MRI) period (1985-1997). The estimated annual percent change was calculated based on linear regression analyses using SEER*STAT. The incidence of PCNSL appears to be increasing in all SEER registries examined. All age groups demonstrated an increase over time. This increase was observed both in the CT era as well as in the MRI era. PCNSL age-adjusted incidence (0.15 to 0.48, a 3-fold increase) outpaced that of systemic lymphoma (14.1 to 18.5, a 33% increase) for the same registries over the same time periods. The rate of increase has begun to slow since 1985; the estimated annual percent change for PCNSL was three-fold higher during the period 1973-1985 compared with 1986-1997. The incidence rate of PCNSL continues to rise. The increase is evident in all age groups and in both genders. Data from the current study suggest that improved diagnostic tools, such as CT or MRI, cannot explain this increase.
doi_str_mv 10.1002/cncr.10851
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_72107948</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>72107948</sourcerecordid><originalsourceid>FETCH-LOGICAL-c272t-7f1087dcf1beb9340ef3474dfaac94a5f6205d0fa33871cc7c38debfe02ed0503</originalsourceid><addsrcrecordid>eNpFkd9qFTEQxoMo9rR64wNIbvRCupo_m2bXu1JaKxQEqeDdkpNMzolmk2Nmt7BP4uuaYxd6EWYGfvmY-T5C3nD2kTMmPtlkS-06xZ-RDWe9bhhvxXOyYYx1jWrlzxNyivirjloo-ZKccCGk7nm_IX_v90BtTlNIc0g7GqoWGITa0Gl_LDY4SBZo9vRQwmjKQi2kqZhIE5SHPCPFBScYacqpuc1u97v-jct42OfRfKaXFOfyACFGU2XOKRyq4BhyzLvlnJrk6HV93wHnOGGdTVww4CvywpuI8HqtZ-THzfX91W1z9-3L16vLu8YKLaZG-3q3dtbzLWx72TLwstWt88bYvjXKXwimHPNGyk5za7WVnYOtBybAMcXkGXn_qHso-c8MOA1jQAvHZaGeNmjBme7broIfHkFbMmIBP6xuDJwNxxiGYwzD_xgq_HZVnbcjuCd09b0C71bAoDXRl-pNwCdO9kJdKCX_ASnjlCs</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>72107948</pqid></control><display><type>article</type><title>The continuing increase in the incidence of primary central nervous system non-Hodgkin lymphoma: A surveillance, epidemiology, and End Results analysis</title><source>Wiley Free Content</source><source>MEDLINE</source><source>Wiley Online Library Journals Frontfile Complete</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>Alma/SFX Local Collection</source><creator>OLSON, Janet E ; JANNEY, Carol A ; RAO, Ravi D ; CERHAN, James R ; KURTIN, Paul J ; SCHIFF, David ; KAPLAN, Richard S ; O'NEILL, Brian Patrick</creator><creatorcontrib>OLSON, Janet E ; JANNEY, Carol A ; RAO, Ravi D ; CERHAN, James R ; KURTIN, Paul J ; SCHIFF, David ; KAPLAN, Richard S ; O'NEILL, Brian Patrick</creatorcontrib><description>Primary central nervous system lymphoma (PCNSL) is an extranodal form of non-Hodgkin lymphoma arising in the craniospinal axis. The incidence of PCNSL appears to be increasing. PCNSL incidence data from 1973-1997 were obtained from the nine Surveillance, Epidemiology and End Results (SEER) registries. To limit the influence of the human immunodeficiency virus on incidence rates, data of never-married males and females and persons of unknown marital status were excluded. As a surrogate for new technology, SEER data were reviewed by dates of diagnosis (surrogate for imaging) and compared with glioma incidence (surrogate for stereotactic neurosurgery and improved diagnostic neuropathology). Age-adjusted incidence rates were estimated and compared for the period prior to computed tomography (CT) (1973-1984) and the magnetic resonance imaging (MRI) period (1985-1997). The estimated annual percent change was calculated based on linear regression analyses using SEER*STAT. The incidence of PCNSL appears to be increasing in all SEER registries examined. All age groups demonstrated an increase over time. This increase was observed both in the CT era as well as in the MRI era. PCNSL age-adjusted incidence (0.15 to 0.48, a 3-fold increase) outpaced that of systemic lymphoma (14.1 to 18.5, a 33% increase) for the same registries over the same time periods. The rate of increase has begun to slow since 1985; the estimated annual percent change for PCNSL was three-fold higher during the period 1973-1985 compared with 1986-1997. The incidence rate of PCNSL continues to rise. The increase is evident in all age groups and in both genders. Data from the current study suggest that improved diagnostic tools, such as CT or MRI, cannot explain this increase.</description><identifier>ISSN: 0008-543X</identifier><identifier>EISSN: 1097-0142</identifier><identifier>DOI: 10.1002/cncr.10851</identifier><identifier>PMID: 12237919</identifier><identifier>CODEN: CANCAR</identifier><language>eng</language><publisher>New York, NY: Wiley-Liss</publisher><subject>Adult ; Aged ; Aged, 80 and over ; Biological and medical sciences ; Central Nervous System Neoplasms - epidemiology ; Epidemiologic Studies ; Female ; Hematologic and hematopoietic diseases ; Humans ; Incidence ; Leukemias. Malignant lymphomas. Malignant reticulosis. Myelofibrosis ; Lymphoma, Non-Hodgkin - epidemiology ; Male ; Medical sciences ; Middle Aged ; SEER Program</subject><ispartof>Cancer, 2002-10, Vol.95 (7), p.1504-1510</ispartof><rights>2002 INIST-CNRS</rights><rights>Copyright 2002 American Cancer Society.DOI 10.1002/cncr.10851</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c272t-7f1087dcf1beb9340ef3474dfaac94a5f6205d0fa33871cc7c38debfe02ed0503</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27903,27904</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=13925655$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/12237919$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>OLSON, Janet E</creatorcontrib><creatorcontrib>JANNEY, Carol A</creatorcontrib><creatorcontrib>RAO, Ravi D</creatorcontrib><creatorcontrib>CERHAN, James R</creatorcontrib><creatorcontrib>KURTIN, Paul J</creatorcontrib><creatorcontrib>SCHIFF, David</creatorcontrib><creatorcontrib>KAPLAN, Richard S</creatorcontrib><creatorcontrib>O'NEILL, Brian Patrick</creatorcontrib><title>The continuing increase in the incidence of primary central nervous system non-Hodgkin lymphoma: A surveillance, epidemiology, and End Results analysis</title><title>Cancer</title><addtitle>Cancer</addtitle><description>Primary central nervous system lymphoma (PCNSL) is an extranodal form of non-Hodgkin lymphoma arising in the craniospinal axis. The incidence of PCNSL appears to be increasing. PCNSL incidence data from 1973-1997 were obtained from the nine Surveillance, Epidemiology and End Results (SEER) registries. To limit the influence of the human immunodeficiency virus on incidence rates, data of never-married males and females and persons of unknown marital status were excluded. As a surrogate for new technology, SEER data were reviewed by dates of diagnosis (surrogate for imaging) and compared with glioma incidence (surrogate for stereotactic neurosurgery and improved diagnostic neuropathology). Age-adjusted incidence rates were estimated and compared for the period prior to computed tomography (CT) (1973-1984) and the magnetic resonance imaging (MRI) period (1985-1997). The estimated annual percent change was calculated based on linear regression analyses using SEER*STAT. The incidence of PCNSL appears to be increasing in all SEER registries examined. All age groups demonstrated an increase over time. This increase was observed both in the CT era as well as in the MRI era. PCNSL age-adjusted incidence (0.15 to 0.48, a 3-fold increase) outpaced that of systemic lymphoma (14.1 to 18.5, a 33% increase) for the same registries over the same time periods. The rate of increase has begun to slow since 1985; the estimated annual percent change for PCNSL was three-fold higher during the period 1973-1985 compared with 1986-1997. The incidence rate of PCNSL continues to rise. The increase is evident in all age groups and in both genders. Data from the current study suggest that improved diagnostic tools, such as CT or MRI, cannot explain this increase.</description><subject>Adult</subject><subject>Aged</subject><subject>Aged, 80 and over</subject><subject>Biological and medical sciences</subject><subject>Central Nervous System Neoplasms - epidemiology</subject><subject>Epidemiologic Studies</subject><subject>Female</subject><subject>Hematologic and hematopoietic diseases</subject><subject>Humans</subject><subject>Incidence</subject><subject>Leukemias. Malignant lymphomas. Malignant reticulosis. Myelofibrosis</subject><subject>Lymphoma, Non-Hodgkin - epidemiology</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Middle Aged</subject><subject>SEER Program</subject><issn>0008-543X</issn><issn>1097-0142</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2002</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNpFkd9qFTEQxoMo9rR64wNIbvRCupo_m2bXu1JaKxQEqeDdkpNMzolmk2Nmt7BP4uuaYxd6EWYGfvmY-T5C3nD2kTMmPtlkS-06xZ-RDWe9bhhvxXOyYYx1jWrlzxNyivirjloo-ZKccCGk7nm_IX_v90BtTlNIc0g7GqoWGITa0Gl_LDY4SBZo9vRQwmjKQi2kqZhIE5SHPCPFBScYacqpuc1u97v-jct42OfRfKaXFOfyACFGU2XOKRyq4BhyzLvlnJrk6HV93wHnOGGdTVww4CvywpuI8HqtZ-THzfX91W1z9-3L16vLu8YKLaZG-3q3dtbzLWx72TLwstWt88bYvjXKXwimHPNGyk5za7WVnYOtBybAMcXkGXn_qHso-c8MOA1jQAvHZaGeNmjBme7broIfHkFbMmIBP6xuDJwNxxiGYwzD_xgq_HZVnbcjuCd09b0C71bAoDXRl-pNwCdO9kJdKCX_ASnjlCs</recordid><startdate>20021001</startdate><enddate>20021001</enddate><creator>OLSON, Janet E</creator><creator>JANNEY, Carol A</creator><creator>RAO, Ravi D</creator><creator>CERHAN, James R</creator><creator>KURTIN, Paul J</creator><creator>SCHIFF, David</creator><creator>KAPLAN, Richard S</creator><creator>O'NEILL, Brian Patrick</creator><general>Wiley-Liss</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20021001</creationdate><title>The continuing increase in the incidence of primary central nervous system non-Hodgkin lymphoma: A surveillance, epidemiology, and End Results analysis</title><author>OLSON, Janet E ; JANNEY, Carol A ; RAO, Ravi D ; CERHAN, James R ; KURTIN, Paul J ; SCHIFF, David ; KAPLAN, Richard S ; O'NEILL, Brian Patrick</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c272t-7f1087dcf1beb9340ef3474dfaac94a5f6205d0fa33871cc7c38debfe02ed0503</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2002</creationdate><topic>Adult</topic><topic>Aged</topic><topic>Aged, 80 and over</topic><topic>Biological and medical sciences</topic><topic>Central Nervous System Neoplasms - epidemiology</topic><topic>Epidemiologic Studies</topic><topic>Female</topic><topic>Hematologic and hematopoietic diseases</topic><topic>Humans</topic><topic>Incidence</topic><topic>Leukemias. Malignant lymphomas. Malignant reticulosis. Myelofibrosis</topic><topic>Lymphoma, Non-Hodgkin - epidemiology</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Middle Aged</topic><topic>SEER Program</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>OLSON, Janet E</creatorcontrib><creatorcontrib>JANNEY, Carol A</creatorcontrib><creatorcontrib>RAO, Ravi D</creatorcontrib><creatorcontrib>CERHAN, James R</creatorcontrib><creatorcontrib>KURTIN, Paul J</creatorcontrib><creatorcontrib>SCHIFF, David</creatorcontrib><creatorcontrib>KAPLAN, Richard S</creatorcontrib><creatorcontrib>O'NEILL, Brian Patrick</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Cancer</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>OLSON, Janet E</au><au>JANNEY, Carol A</au><au>RAO, Ravi D</au><au>CERHAN, James R</au><au>KURTIN, Paul J</au><au>SCHIFF, David</au><au>KAPLAN, Richard S</au><au>O'NEILL, Brian Patrick</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>The continuing increase in the incidence of primary central nervous system non-Hodgkin lymphoma: A surveillance, epidemiology, and End Results analysis</atitle><jtitle>Cancer</jtitle><addtitle>Cancer</addtitle><date>2002-10-01</date><risdate>2002</risdate><volume>95</volume><issue>7</issue><spage>1504</spage><epage>1510</epage><pages>1504-1510</pages><issn>0008-543X</issn><eissn>1097-0142</eissn><coden>CANCAR</coden><abstract>Primary central nervous system lymphoma (PCNSL) is an extranodal form of non-Hodgkin lymphoma arising in the craniospinal axis. The incidence of PCNSL appears to be increasing. PCNSL incidence data from 1973-1997 were obtained from the nine Surveillance, Epidemiology and End Results (SEER) registries. To limit the influence of the human immunodeficiency virus on incidence rates, data of never-married males and females and persons of unknown marital status were excluded. As a surrogate for new technology, SEER data were reviewed by dates of diagnosis (surrogate for imaging) and compared with glioma incidence (surrogate for stereotactic neurosurgery and improved diagnostic neuropathology). Age-adjusted incidence rates were estimated and compared for the period prior to computed tomography (CT) (1973-1984) and the magnetic resonance imaging (MRI) period (1985-1997). The estimated annual percent change was calculated based on linear regression analyses using SEER*STAT. The incidence of PCNSL appears to be increasing in all SEER registries examined. All age groups demonstrated an increase over time. This increase was observed both in the CT era as well as in the MRI era. PCNSL age-adjusted incidence (0.15 to 0.48, a 3-fold increase) outpaced that of systemic lymphoma (14.1 to 18.5, a 33% increase) for the same registries over the same time periods. The rate of increase has begun to slow since 1985; the estimated annual percent change for PCNSL was three-fold higher during the period 1973-1985 compared with 1986-1997. The incidence rate of PCNSL continues to rise. The increase is evident in all age groups and in both genders. Data from the current study suggest that improved diagnostic tools, such as CT or MRI, cannot explain this increase.</abstract><cop>New York, NY</cop><pub>Wiley-Liss</pub><pmid>12237919</pmid><doi>10.1002/cncr.10851</doi><tpages>7</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0008-543X
ispartof Cancer, 2002-10, Vol.95 (7), p.1504-1510
issn 0008-543X
1097-0142
language eng
recordid cdi_proquest_miscellaneous_72107948
source Wiley Free Content; MEDLINE; Wiley Online Library Journals Frontfile Complete; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; Alma/SFX Local Collection
subjects Adult
Aged
Aged, 80 and over
Biological and medical sciences
Central Nervous System Neoplasms - epidemiology
Epidemiologic Studies
Female
Hematologic and hematopoietic diseases
Humans
Incidence
Leukemias. Malignant lymphomas. Malignant reticulosis. Myelofibrosis
Lymphoma, Non-Hodgkin - epidemiology
Male
Medical sciences
Middle Aged
SEER Program
title The continuing increase in the incidence of primary central nervous system non-Hodgkin lymphoma: A surveillance, epidemiology, and End Results analysis
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-27T15%3A21%3A18IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=The%20continuing%20increase%20in%20the%20incidence%20of%20primary%20central%20nervous%20system%20non-Hodgkin%20lymphoma:%20A%20surveillance,%20epidemiology,%20and%20End%20Results%20analysis&rft.jtitle=Cancer&rft.au=OLSON,%20Janet%20E&rft.date=2002-10-01&rft.volume=95&rft.issue=7&rft.spage=1504&rft.epage=1510&rft.pages=1504-1510&rft.issn=0008-543X&rft.eissn=1097-0142&rft.coden=CANCAR&rft_id=info:doi/10.1002/cncr.10851&rft_dat=%3Cproquest_cross%3E72107948%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=72107948&rft_id=info:pmid/12237919&rfr_iscdi=true